Delivery Order SPE2DR25D3501-SPE2DR26FM3FD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,615.80 for Ferumoxytol 510 mg/17 ml vials on January 20, 2026, with completion scheduled for January 21, 2026. This is a firm fixed-price, non-set-aside award issued under a competitive procurement process. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a $9,829.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ferumoxytol 510 mg/17 ml vials. The contract is a non-set-aside award with an ultimate completion date of January 9, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $2,702.00 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials with a ceiling value of $5,165.40. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger pharmaceutical supply vehicle with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $40,702.19. The award, issued on November 14, 2025, is a firm fixed price delivery order with an ultimate completion date of November 17, 2025. This contract represents a non-competitive set-aside award, indicating the vendor was selected through open competition to supply this specialized pharmaceutical product. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials, with a ceiling value of $1,491.43 and an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,720.55 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the awardee's location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $17,822 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials, with an ultimate completion date of January 27, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a ceiling value of $1,825.10. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by November 28, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM3FDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of Cencora, Inc.) on January 27, 2026, for the supply of Ferumoxytol 510 mg/17 mL vials valued at $2,615.80, with completion expected by January 28, 2026. The award utilizes a firm fixed-price structure with no set-aside designation, indicating full and open competition. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, the headquarters of AmerisourceBergen's corporate operations. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at up to $999,999,999.00 and extends through December 2026. The parent IDC provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen's extensive federal contract portfolio demonstrates its role as a critical vendor for military and veteran healthcare systems, with consistent awards reflecting the company's capability to fulfill federal procurement requirements efficiently across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 1/26/26 |